CYP2C9*6 AND Flurbiprofen response
- Germline classification:
- drug response (1 submission)
- Last evaluated:
- Feb 11, 2019
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000787932.2
Allele description [Variation Report for CYP2C9*6]
CYP2C9*6
Condition(s)
- Name:
- Flurbiprofen response
- Synonyms:
- Ocufen response; Ansaid response
- Identifiers:
- MedGen: CN258139
Assertion and evidence details
Last Updated: Feb 14, 2024